Serum Light Chain Analysis available PRIVATELY in Ontario @ $300 plus Courier service. Govt. pays in selected Cancer clinics.
Monitoring patients with monoclonal light chain diseases but no M-spike on protein electrophoresis
Clinical Information Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory testThe monoclonal gammopathies are characterized by a clonal expansion of plasma cells that secrete a monoclonal immunoglobulin (Ig). The monoclonal Ig secreted by these cells serves as a marker of the clonal proliferation, and the quantitation of monoclonal protein can be used to monitor the disease course.
The monoclonal gammopathies include multiple myeloma (MM), light chain multiple myeloma (LCMM), Waldenstrom’s macroglobulinemia (WM), nonsecretory myeloma (NSMM), smoldering multiple myeloma (SMM), monoclonal gammopathy of undetermined significance (MGUS), primary systemic amyloidosis (AL), and light chain deposition disease (LCDD).
Monoclonal proteins are typically detected by serum protein electrophoresis (SPEP) and immunofixation (IF). However, the monoclonal light chain diseases (LCMM, AL, LCDD) and NSMM often do not have serum monoclonal proteins in high enough concentration to be detected and quantitated by SPEP.
A sensitive nephelometric assay specific for kappa free light chain (FLC) that doesn’t recognize light chains bound to Ig heavy chains has recently been described. This automated, nephelometric assay is reported to be more sensitive than IF for detection of monoclonal FLC. In some patients with NSMM, AL, or LCDD the FLC assay provides a positive identification of a monoclonal serum light chain when the serum IF is negative. In addition, the quantitation of FLC has been correlated with disease activity in patients with NSMM and AL.
See Laboratory Approach to the Diagnosis of Amyloidosis and Laboratory Screening Tests for Suspected Multiple Myeloma in Special Instructions.
Reference Values Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.KAPPA-FREE LIGHT CHAIN
0.33-1.94 mg/dL
LAMBDA-FREE LIGHT CHAIN
0.57-2.63 mg/dL
KAPPA/LAMBDA FLC RATIO
0.26-1.65
Interpretation Provides information to assist in interpretation of the test resultsThe specificity of this assay for detection of monoclonal light chains relies on the ratio of free kappa and lambda light chains. Once an abnormal free light chain (FLC) K/L ratio has been demonstrated and a diagnosis has been made, the quantitation of the monoclonal light chain is useful for monitoring disease activity.
Changes in FLC quantitation reflect changes in the size of the monoclonal plasma cell population. Our experience to date is limited, but changes of >25% or trending of multiple specimens are needed to conclude biological significance.
Cautions Discusses conditions that may cause diagnostic confusion, including improper specimen collection and handling, inappropriate test selection, and interfering substancesElevated kappa and lambda free light chain (FLC) may occur due to polyclonal hypergammaglobulinemia or impaired renal clearance. A specific increase in FLC (eg, FLC K/L ratio) must be demonstrated for diagnostic purposes.
Moderate to marked lipemia may interfere with the ability to perform testing.
Supportive Data
Studies at Mayo Clinic have shown that in some patients with urine monoclonal light chains and negative serum immunofixation (IF), the free light chain (FLC) assay can identify monoclonal FLC in the serum. These studies support the increased sensitivity of the nephelometric FLC assay. In a series of patients with primary systemic amyloid treated by stem cell transplantation, the quantitation and monitoring of FLC predicted organ response (eg, disease course).
Clinical Reference Provides recommendations for further in-depth reading of a clinical natureDrayson M, Tang LX, Drew R, et al: Serum free light chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma. Blood 2001;97(9):2900-2902
30 November 2011
29 November 2011
UK DAILY MAIL: COST of AIDS
MOUNTING COSTS OF HIV TREATMENT
The cost of treating someone with HIV in the UK is estimated to be around £18,000 per year when they are not showing any symptoms.
This is based on the price of care as well as triple-drug antiretroviral therapy.
However, it costs £21,500 to treat patients who are showing symptoms and £41,000 for those with full-blown AIDS.
Patients who have four drugs cost the NHS between £22,775 and £48,000 per year.
The annual cost of providing HIV treatment and care in the UK could be as high as £758 million by 2013, according to a study in PLoS One.
Read more: http://www.dailymail.co.uk/health/article-2067496/Number-people-HIV-UK-poised-hit-100-000-infections-rise-6-year.html#ixzz1f6DXIu6F
The cost of treating someone with HIV in the UK is estimated to be around £18,000 per year when they are not showing any symptoms.
This is based on the price of care as well as triple-drug antiretroviral therapy.
However, it costs £21,500 to treat patients who are showing symptoms and £41,000 for those with full-blown AIDS.
Patients who have four drugs cost the NHS between £22,775 and £48,000 per year.
The annual cost of providing HIV treatment and care in the UK could be as high as £758 million by 2013, according to a study in PLoS One.
Read more: http://www.dailymail.co.uk/health/article-2067496/Number-people-HIV-UK-poised-hit-100-000-infections-rise-6-year.html#ixzz1f6DXIu6F
24 November 2011
UK DAILY MAIL Swedish AIRSONETT Inc. PROTEXO Temperature controlled Laminar airflow
By Daily Mail Reporter
Children with asthma are taking part in a trial to see if the Airsonett machine, which sucks up dust, can reduce their symptoms
A machine that hangs over the bed cleaning the surrounding air could ease night-time wheezing for asthmatics.
The so-called 'air vacuum' sucks up allergens and dust particles that could trigger attacks.
The £2,000 Airsonett machine uses the same technology deployed by manufacturing industries to create sterile environments by removing dust particles from the air.
Now a trial is under way at St Mary's Hospital in London involving 75 children with asthma to see if the device can reduce their symptoms.
More than five million people in the UK suffer with asthma, including at least one million children.
The year-long trial, due to end next summer, is comparing real 'air vacuum' machines with dummy ones.
Read more: http://www.dailymail.co.uk/health/article-1077369/Could-vacuum-sucks-allergens-stop-night-time-wheezing-asthma-sufferers.html#ixzz1efi515z7
http://www.airsonett.com/
Children with asthma are taking part in a trial to see if the Airsonett machine, which sucks up dust, can reduce their symptoms
A machine that hangs over the bed cleaning the surrounding air could ease night-time wheezing for asthmatics.
The so-called 'air vacuum' sucks up allergens and dust particles that could trigger attacks.
The £2,000 Airsonett machine uses the same technology deployed by manufacturing industries to create sterile environments by removing dust particles from the air.
Now a trial is under way at St Mary's Hospital in London involving 75 children with asthma to see if the device can reduce their symptoms.
More than five million people in the UK suffer with asthma, including at least one million children.
The year-long trial, due to end next summer, is comparing real 'air vacuum' machines with dummy ones.
Read more: http://www.dailymail.co.uk/health/article-1077369/Could-vacuum-sucks-allergens-stop-night-time-wheezing-asthma-sufferers.html#ixzz1efi515z7
http://www.airsonett.com/
19 November 2011
COCKROACH SENSITIVITY in Allergic Rhinitis.
POSTER PRESENTATION Open Access
Cockroach sensitivity in allergic rhinitis patients;
is it significant? To see prevalence of cockroach
sensitivity in allergic rhinitis patients in
Kingston area
Tahira Batool*, Rozita Borici-Mazi
From Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting 2010
Victoria, Canada. 3-6 November 2010
Background
Role of cockroach allergy in asthma has been widely studied
and the effect of environmental control on asthma
symptoms has been established. However, the role of
cockroach sensitivity remains unknown. We have
designed this study to establish role of cockroach sensitization
on allergic rhinitis.
Hypothesis
Cockroach allergy has significant role in allergic rhinitis.
Population
Allergic rhinitis patients attending allergy and clinical
immunology clinic under Dr Rozita Borici-Mazi in Kingston
General Hospital, Kingston ON.
Method
Retrospective chart review of patients evaluated for
allergic rhinitis and underwent skin prick testing.
A cohort of 250 patients was randomly selected with
inclusion criteria being symptomatic allergic rhinitis and
positive allergy skin prick testing to usual panel of allergens.
Data collection included demographics, smoking
exposure, symptom pattern, presence or absence of
non-nasal symptoms, positive skin prick testing for
cockroach and other environmental allergens such as
dust mite, cat, dog, and seasonal pollens.
Results
Allergy to seasonal allergens was found to be the most
common (n=191, 76.4%) followed by house dust mite
(n=149, 59.6%) and cat allergen (n=118, 47.2%). Cockroach
sensitization was found in 62 (25%). Among the
cockroach sensitivity group, 8 patients had monosensitization
to cockroach. All of them had perennial symptoms.
75%of these people were residents of urban areas.
Two patients who had symptoms for more than 8 years
had developed asthma.
Conclusion
Cockroach allergy is found to be one of the significant
indoor allergens in allergic rhinitis in Kingston area.
Given the relationship of Allergic Rhinitis and Asthma
development, there is need to recognize this important
allergen earlier and treat it through allergen avoidance
and/or Immunotherapy, not only to treat allergic rhinitis
symptoms but also to prevent development of allergic
asthma. Further studies to establish the correlation
between allergic rhinitis and cockroach sensitization are
needed.
Published: 4 November 2010
doi:10.1186/1710-1492-6-S2-P11
Cite this article as: Batool and Borici-Mazi: Cockroach sensitivity in
allergic rhinitis patients; is it significant? To see prevalence of cockroach
sensitivity in allergic rhinitis patients in Kingston area. Allergy, Asthma &
Clinical Immunology 2010 6(Suppl 2):P11.
* Correspondence: 7TB11@queensu.ca
Department of Internal Medicine, Queen’s University, Kingston, Ontario,
Ann Allergy. 1978 Dec;41(6):333-6.
A comparative study of prevalence of skin hypersensitivity to cockroach and house dust antigens.
Kang B, Sulit N.
Abstract
Allergy skin tests with cockroach antigen along with various common inhalant allergens were performed on 222 atopic and on 63 non-atopic subjects. The most prevalent allergen producing a positive skin test was house dust antigen with a positive response of 72%, 78% and 57% in atopic adults, atopic children and non-atopic children, respectively. The next prevalent positive skin test was to cockroach antigen with 50%, 60% and 27%, respectively, of the three groups tested. The differences between positive cockroach hypersensitivity and house dust hypersensitivity in all three groups tested were statistically significant. Next in order of prevalence of positive skin test to common inhalants were western weeds, ragweeds and cats. Incidence of cockroach hypersensitivity was 58% among asthmatic adults and 69% among asthmatic children. The results indicate that cockroach hypersensitivity is highly prevalent and that cockroach antigen is an independent agent from house dust as a cause of immediate hypersensitivity reaction.
PMID: 569451 [PubMed - indexed for MEDLINE
WISEMAN RD, WOODIN WG, MILLER HC, MYERS MA. Insect allergy as a possible cause of inhalant sensitivity. J Allergy. 1959 May–Jun;30(3):191–197. [PubMed]
Cockroach sensitivity in allergic rhinitis patients;
is it significant? To see prevalence of cockroach
sensitivity in allergic rhinitis patients in
Kingston area
Tahira Batool*, Rozita Borici-Mazi
From Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting 2010
Victoria, Canada. 3-6 November 2010
Background
Role of cockroach allergy in asthma has been widely studied
and the effect of environmental control on asthma
symptoms has been established. However, the role of
cockroach sensitivity remains unknown. We have
designed this study to establish role of cockroach sensitization
on allergic rhinitis.
Hypothesis
Cockroach allergy has significant role in allergic rhinitis.
Population
Allergic rhinitis patients attending allergy and clinical
immunology clinic under Dr Rozita Borici-Mazi in Kingston
General Hospital, Kingston ON.
Method
Retrospective chart review of patients evaluated for
allergic rhinitis and underwent skin prick testing.
A cohort of 250 patients was randomly selected with
inclusion criteria being symptomatic allergic rhinitis and
positive allergy skin prick testing to usual panel of allergens.
Data collection included demographics, smoking
exposure, symptom pattern, presence or absence of
non-nasal symptoms, positive skin prick testing for
cockroach and other environmental allergens such as
dust mite, cat, dog, and seasonal pollens.
Results
Allergy to seasonal allergens was found to be the most
common (n=191, 76.4%) followed by house dust mite
(n=149, 59.6%) and cat allergen (n=118, 47.2%). Cockroach
sensitization was found in 62 (25%). Among the
cockroach sensitivity group, 8 patients had monosensitization
to cockroach. All of them had perennial symptoms.
75%of these people were residents of urban areas.
Two patients who had symptoms for more than 8 years
had developed asthma.
Conclusion
Cockroach allergy is found to be one of the significant
indoor allergens in allergic rhinitis in Kingston area.
Given the relationship of Allergic Rhinitis and Asthma
development, there is need to recognize this important
allergen earlier and treat it through allergen avoidance
and/or Immunotherapy, not only to treat allergic rhinitis
symptoms but also to prevent development of allergic
asthma. Further studies to establish the correlation
between allergic rhinitis and cockroach sensitization are
needed.
Published: 4 November 2010
doi:10.1186/1710-1492-6-S2-P11
Cite this article as: Batool and Borici-Mazi: Cockroach sensitivity in
allergic rhinitis patients; is it significant? To see prevalence of cockroach
sensitivity in allergic rhinitis patients in Kingston area. Allergy, Asthma &
Clinical Immunology 2010 6(Suppl 2):P11.
* Correspondence: 7TB11@queensu.ca
Department of Internal Medicine, Queen’s University, Kingston, Ontario,
Ann Allergy. 1978 Dec;41(6):333-6.
A comparative study of prevalence of skin hypersensitivity to cockroach and house dust antigens.
Kang B, Sulit N.
Abstract
Allergy skin tests with cockroach antigen along with various common inhalant allergens were performed on 222 atopic and on 63 non-atopic subjects. The most prevalent allergen producing a positive skin test was house dust antigen with a positive response of 72%, 78% and 57% in atopic adults, atopic children and non-atopic children, respectively. The next prevalent positive skin test was to cockroach antigen with 50%, 60% and 27%, respectively, of the three groups tested. The differences between positive cockroach hypersensitivity and house dust hypersensitivity in all three groups tested were statistically significant. Next in order of prevalence of positive skin test to common inhalants were western weeds, ragweeds and cats. Incidence of cockroach hypersensitivity was 58% among asthmatic adults and 69% among asthmatic children. The results indicate that cockroach hypersensitivity is highly prevalent and that cockroach antigen is an independent agent from house dust as a cause of immediate hypersensitivity reaction.
PMID: 569451 [PubMed - indexed for MEDLINE
WISEMAN RD, WOODIN WG, MILLER HC, MYERS MA. Insect allergy as a possible cause of inhalant sensitivity. J Allergy. 1959 May–Jun;30(3):191–197. [PubMed]
16 November 2011
Dutch Society for Free Will End-of-Life: Mobile Euthanasia Teams
De TELEGRAAF
NVVE lanceert mobiele teams voor euthanasie AMSTERDAM - De Nederlandse Vereniging voor een Vrijwillig Levenseinde (NVVE) wil reizende teams opzetten met gespecialiseerde artsen om bij mensen thuis euthanasie toe te passen. De NVVE doet dit omdat veel zieken en ouderen door artsen niet serieus worden genomen in hun stervenswens, heeft een woordvoerster woensdag laten weten. Volgens de criteria van de euthanasiewet zou deze groep wel in aanmerking komen voor euthanasie, zo stelt de NVVE. Nederland zou het eerste land ter wereld worden met dergelijke ambulante teams.
NVVE lanceert mobiele teams voor euthanasie AMSTERDAM - De Nederlandse Vereniging voor een Vrijwillig Levenseinde (NVVE) wil reizende teams opzetten met gespecialiseerde artsen om bij mensen thuis euthanasie toe te passen. De NVVE doet dit omdat veel zieken en ouderen door artsen niet serieus worden genomen in hun stervenswens, heeft een woordvoerster woensdag laten weten. Volgens de criteria van de euthanasiewet zou deze groep wel in aanmerking komen voor euthanasie, zo stelt de NVVE. Nederland zou het eerste land ter wereld worden met dergelijke ambulante teams.
14 November 2011
BIONIME Inc. TAIWAN - SWISS BLOOD SUGAR TESTER.
Swiss-design elegant pocket phone-like Blood Sugar tester. Easy-to-handle test strips. Swiss designed RIGHTEST GD500 Lancing device. RIGHTEST Control Normal & High blood sugar solution included.
Swiss (injection systems) YPSOMED AG (CEO R.FRITCHI) bought 10% of Taiwan BIONIME Inc. (CEO R.HUANG) for CHF 6.5 million.
產品分類
PRODUCTS
GM100 Series
Acquire“Innovation Award” from Mediphar Taipei
No coding
Noble Metal Electrode Strip
High Accuracy & Precision
GM300 Series
Noble Metal Electrode Strip
Smart Code Key
High Accuracy & Precision
Wide LCD screen
GM210 Series
Noble Metal Electrode Strip
Smart Code Key
High Accuracy & Precision
Wide LCD screen
GM550 Series
Auto coding (Patent Pending)
Backlight
Noble Metal Electrode Strip
High Accuracy & Precision
Swiss (injection systems) YPSOMED AG (CEO R.FRITCHI) bought 10% of Taiwan BIONIME Inc. (CEO R.HUANG) for CHF 6.5 million.
產品分類
PRODUCTS
GM100 Series
Acquire“Innovation Award” from Mediphar Taipei
No coding
Noble Metal Electrode Strip
High Accuracy & Precision
GM300 Series
Noble Metal Electrode Strip
Smart Code Key
High Accuracy & Precision
Wide LCD screen
GM210 Series
Noble Metal Electrode Strip
Smart Code Key
High Accuracy & Precision
Wide LCD screen
GM550 Series
Auto coding (Patent Pending)
Backlight
Noble Metal Electrode Strip
High Accuracy & Precision
CANADA: (Quebec) HYGIE "cloth" changes fluid to GEL
HYGIE "cloth" converts fluid to a GEL. Coverts body liquids to a firm gel. Plastic male urinal used by truckers and especially by elderly males to avoid getting up at night; risk of falls and fractures reduced
Sold by Quebec pharmacies.
Sold by Quebec pharmacies.
BAYER point-of-care HbA1c test using capillary blood & "A1CNow+" monitor
A1CNow+®
Fast. Easy. Accurate.
Get A1C test results now in just 5 minutes. The A1CNow+® monitor is hand-held, portable and simple to use. Test results are lab accurate at 99%1.
The A1CNow+® monitor enables you to get rapid A1c test results while your patients are in your office, empowering you to make on-the-spot treatment decisions for your diabetes patients.
Using the A1CNow+® monitor is:
Fast.
In office testing. No waiting for lab results
Results in just five minutes
Hands-on procedure time is less than one minute
Provides opportunity for immediate, face-to-face counseling
Easy.
Simple, 3-step procedure
CLIA waived
Only 5 μL of blood from a fingertip is needed
No calibration, no daily controls, no maintenance
No refrigeration necessary if used within four months
No capital equipment required
Enables A1C testing in every exam room
Accurate.
Proven lab accuracy at 99%
NGSP certified
To learn more about purchasing A1CNow+® for use in your practice, please contact your Bayer sales representative or call our Customer Support Line at 1-800-268-7200.
(In Ontario not covered by Provincial Insurance. Sold by local pharmacies for approx $15 a test.)
Fast. Easy. Accurate.
Get A1C test results now in just 5 minutes. The A1CNow+® monitor is hand-held, portable and simple to use. Test results are lab accurate at 99%1.
The A1CNow+® monitor enables you to get rapid A1c test results while your patients are in your office, empowering you to make on-the-spot treatment decisions for your diabetes patients.
Using the A1CNow+® monitor is:
Fast.
In office testing. No waiting for lab results
Results in just five minutes
Hands-on procedure time is less than one minute
Provides opportunity for immediate, face-to-face counseling
Easy.
Simple, 3-step procedure
CLIA waived
Only 5 μL of blood from a fingertip is needed
No calibration, no daily controls, no maintenance
No refrigeration necessary if used within four months
No capital equipment required
Enables A1C testing in every exam room
Accurate.
Proven lab accuracy at 99%
NGSP certified
To learn more about purchasing A1CNow+® for use in your practice, please contact your Bayer sales representative or call our Customer Support Line at 1-800-268-7200.
(In Ontario not covered by Provincial Insurance. Sold by local pharmacies for approx $15 a test.)
11 November 2011
Dusseldorf Heinrich-Heine University Prof N.GATTERMANN MD PhD visits Toronto
Thanks to NOVARTIS sponsorship, Prof. GATTERMANN gave a series of lectures in Canada on MYELODYSPLASTIC SYNDROME (MDS) with special reference to Non-Transferrin-Bound Iron (NTBI) overload trearted by chelating agents such as deferasirox (Exjade).
Approx. 1800 Canadians are affected by MDS.
The cardiotoxic effect of NTBI was emphasised.
Ann.Haematol.(2011) 90:1-10 (Springer)
"Iron overload in MDS-pathophysiology,diagnosis, and complications."
N.Gattermann H.H.U. Dusseldorf, Germany E.Rachmilewitz E.Wolfson Med. Center,Holon, Israel.
Prof Gatterman studied with Late Hepatologist Dame Sheila Sherlock at the Hampstead branch of London's Royal Free Hospital and at the Boston Harvard Medical school. An idiomatically perfect English speaker..
Approx. 1800 Canadians are affected by MDS.
The cardiotoxic effect of NTBI was emphasised.
Ann.Haematol.(2011) 90:1-10 (Springer)
"Iron overload in MDS-pathophysiology,diagnosis, and complications."
N.Gattermann H.H.U. Dusseldorf, Germany E.Rachmilewitz E.Wolfson Med. Center,Holon, Israel.
Prof Gatterman studied with Late Hepatologist Dame Sheila Sherlock at the Hampstead branch of London's Royal Free Hospital and at the Boston Harvard Medical school. An idiomatically perfect English speaker..
05 November 2011
Ontario College Physicians & Surgeons uses Private investigators with secret cameras.
In three published discipline cases`the CPSO used secret cameras and private investigators.
SPYTECH has`details of hidden cameras.
http://www.spytech.com/
In USA some doctors are recording all patient contacts.
Mini Gadgets CD-PRO Pro Camera Detector $1000
SPYTECH has`details of hidden cameras.
http://www.spytech.com/
In USA some doctors are recording all patient contacts.
Mini Gadgets CD-PRO Pro Camera Detector $1000
04 November 2011
New Ontario medical rank: GP with FOCUSED PRACTICE in ...
ONTARIO: GP with FOCUSED PRACTICE a copy of UK GPwSI (GP with Special Interest)
Ontario College Phys & Surgeons (CPSO) has copied UK NHS status of "GPwSI"; above basic GP but below a Specialist. GPwSIs often work as hospital clinic assistants to UK Consultants.
CPSO changed the phrase of "Practice Limited to...."
Now "GP with Focused Practice in..."
The "GP" must be included to le4t the public know that the doctor is NOT a Specialist. (The result of the YAZDANFAR case when a GP who did liposuction killed a patient.)
The new`law will help Specialists who trained abroad but can not or will not take the Canadian specialty exams.
It will also help GPs who want to rise above the herd by taking extra courses. It will also help provide a degree of specialised services in parts of Ontario where Specialists do not want to live.
GP Focused Practice Designation: Policy and Program Overview September 2011 Page 34 of 39 Appendix B: Royal College of Physicians and Surgeons of Canada List of Specialties and Subspecialties Adolescent Medicine
Anatomical Pathology
Anaesthesiology
Cardiac Surgery
Cardiology
Clinical Immunology and Allergy
Clinical Pharmacology
Clinician Investigator Program
Colorectal Surgery
Community Medicine
Critical Care Medicine
Dermatology
Developmental Paediatrics
Diagnostic Radiology
Emergency Medicine
Endocrinology and Metabolism
Forensic Pathology
Gastroenterology
General Pathology
General Surgery
General Surgical Oncology
Geriatric Medicine
Gynecologic Oncology
Gynecologic Reproductive Endocrinology and Infertility
Hematological Pathology
Hematology
Infectious Diseases
Internal Medicine
Maternal-Fetal Medicine
Medical Biochemistry
Medical genetics
Medical Microbiology
Medical Oncology
Neonatal-Perinatal Medicine
Nephrology
Neurology
Neuropathology
Neuroradiology
Neurosurgery
Nuclear Medicine
Obstetrics and Gynecology
Occupational medicine
Ophthalmology
Orthopedic Surgery
Otolaryngology-Head and Neck Surgery
Palliative Medicine
Pediatric Emergency Medicine
Pediatric General Surgery
Ontario College Phys & Surgeons (CPSO) has copied UK NHS status of "GPwSI"; above basic GP but below a Specialist. GPwSIs often work as hospital clinic assistants to UK Consultants.
CPSO changed the phrase of "Practice Limited to...."
Now "GP with Focused Practice in..."
The "GP" must be included to le4t the public know that the doctor is NOT a Specialist. (The result of the YAZDANFAR case when a GP who did liposuction killed a patient.)
The new`law will help Specialists who trained abroad but can not or will not take the Canadian specialty exams.
It will also help GPs who want to rise above the herd by taking extra courses. It will also help provide a degree of specialised services in parts of Ontario where Specialists do not want to live.
GP Focused Practice Designation: Policy and Program Overview September 2011 Page 34 of 39 Appendix B: Royal College of Physicians and Surgeons of Canada List of Specialties and Subspecialties Adolescent Medicine
Anatomical Pathology
Anaesthesiology
Cardiac Surgery
Cardiology
Clinical Immunology and Allergy
Clinical Pharmacology
Clinician Investigator Program
Colorectal Surgery
Community Medicine
Critical Care Medicine
Dermatology
Developmental Paediatrics
Diagnostic Radiology
Emergency Medicine
Endocrinology and Metabolism
Forensic Pathology
Gastroenterology
General Pathology
General Surgery
General Surgical Oncology
Geriatric Medicine
Gynecologic Oncology
Gynecologic Reproductive Endocrinology and Infertility
Hematological Pathology
Hematology
Infectious Diseases
Internal Medicine
Maternal-Fetal Medicine
Medical Biochemistry
Medical genetics
Medical Microbiology
Medical Oncology
Neonatal-Perinatal Medicine
Nephrology
Neurology
Neuropathology
Neuroradiology
Neurosurgery
Nuclear Medicine
Obstetrics and Gynecology
Occupational medicine
Ophthalmology
Orthopedic Surgery
Otolaryngology-Head and Neck Surgery
Palliative Medicine
Pediatric Emergency Medicine
Pediatric General Surgery
Subscribe to:
Posts (Atom)